RECORD // Company
Kalaris Therapeutics, Inc.
Formerly: Allovir, Inc.; ViraCyte, Inc.
Built 2026-11-22T00:09:58Z from public sources · JSON · Open the company profile
ASK THE RECORDS
Ask
COMPANY
Records for this company (1 joined by official identifier)
Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.
SEC EDGAR (1)
- Kalaris Therapeutics, Inc. · the SEC registrant record of this company
Records under a former name (2)
The name on these records was this company's name in the past (SEC name history). An old name can also belong to an unrelated organization, so they are shown apart and are not counted above.
- AlloVir · Ctgov
- ALLOVIR, INC. · East licences
3 VALUES · 10-Q · EACH LINKS TO ITS FILING
Latest quarter
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-10 · accession 0001193125-26-455378
| Item | Value | Period | Form | Filed | Accession | Report | |
|---|---|---|---|---|---|---|---|
| Net income (loss) | $-11,026,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-10 | 0001193125-26-455378 | 2026-11-22 00:09 UTC | Report an error |
| Interest expense | $0 | 3 months ended 2026-09-30 | 10-Q | 2026-11-10 | 0001193125-26-455378 | 2026-11-22 00:09 UTC | Report an error |
| Cash and cash equivalents | $47,384,000 | at 2026-09-30 | 10-Q | 2026-11-10 | 0001193125-26-455378 | 2026-11-22 00:09 UTC | Report an error |
Negative as reported in the filing.
Not in this report's XBRL: Revenue.
Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.
IDS
Identifiers
- SEC CIK
- 0001754068
- Ticker
- KLRS
- EIN
- 831971007
- CUSIP
- 482929106
- Record ID
- sx:sec:0001754068
OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA
Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
29 FACTS · EACH LINKS TO ITS FILING
Facts
| Fact | Value | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-10 | SEC EDGAR company profile | 2026-11-22 00:09 UTC | Report an error |
| SIC industry | 2836 Biological Products, (No Diagnostic Substances) | 2026-11-10 | SEC EDGAR company profile | 2026-11-22 00:09 UTC | Report an error |
| State of incorporation | DE | 2026-11-10 | SEC EDGAR company profile | 2026-11-22 00:09 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-10 | SEC EDGAR company profile | 2026-11-22 00:09 UTC | Report an error |
| Business address | 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922 | 2026-11-10 | SEC EDGAR company profile | 2026-11-22 00:09 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-10 | SEC EDGAR company profile | 2026-11-22 00:09 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | $-43,438,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | 2026-11-22 00:09 UTC | Report an error |
| Total assets (at 2025-12-31) | $121,736,000 | 2025-12-31 | 10-K, XBRL Assets | 2026-11-22 00:09 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $78,814,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | 2026-11-22 00:09 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $98,054,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | 2026-11-22 00:09 UTC | Report an error |
| Operating cash flow (fiscal year ended 2025-12-31) | $-38,370,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | 2026-11-22 00:09 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $200,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | 2026-11-22 00:09 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $1,448,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | 2026-11-22 00:09 UTC | Report an error |
| Form D total offering amount (D filed 2019-05-22) | $121,253,231 | 2019-05-22 | D | 2026-11-22 00:09 UTC | Report an error |
| Form D total amount sold (D filed 2019-05-22) | $121,253,231 | 2019-05-22 | D | 2026-11-22 00:09 UTC | Report an error |
| Form D industry group | Biotechnology | 2019-05-22 | D | 2026-11-22 00:09 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2019-05-22 | D | 2026-11-22 00:09 UTC | Report an error |
| Form D date of first sale | 2019-05-08 | 2019-05-22 | D | 2026-11-22 00:09 UTC | Report an error |
| Plan (pension, plan no. 001) | KALARIS THERAPEUTICS, INC. 401(K) RETIREMENT PLAN: 62 participants, assets $4,834,287 | 2025-12-31 | DOL EBSA Form 5500 public datasets (dataset) | 2026-11-22 00:09 UTC | Report an error |
| Largest institutional holder #1 (13F as filed): SAMSARA BIOCAPITAL, LLC | $52,426,382 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:09 UTC | Report an error |
| Largest institutional holder #2 (13F as filed): RTW INVESTMENTS, LP | $5,291,000 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:09 UTC | Report an error |
| Largest institutional holder #3 (13F as filed): Alyeska Investment Group, L.P. | $2,330,836 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:09 UTC | Report an error |
| Largest institutional holder #4 (13F as filed): Siren, L.L.C. | $1,773,698 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:09 UTC | Report an error |
| Largest institutional holder #5 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC | $1,622,758 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:09 UTC | Report an error |
| Largest institutional holder #6 (13F as filed): Ikarian Capital, LLC | $1,465,201 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:09 UTC | Report an error |
| Largest institutional holder #7 (13F as filed): UBS Group AG | $1,066,873 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:09 UTC | Report an error |
| Largest institutional holder #8 (13F as filed): RENAISSANCE TECHNOLOGIES LLC | $607,859 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:09 UTC | Report an error |
| Largest institutional holder #9 (13F as filed): MARSHALL WACE, LLP | $566,549 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:09 UTC | Report an error |
| Largest institutional holder #10 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC | $464,287 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:09 UTC | Report an error |
EVERY DATED RECORD, NEWEST FIRST
Timeline
- 2026-11-10 Filing 10-Q filed
- 2026-11-10 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-10-13 Filing Form 5500 received for plan year ending 2025-12-31 (plan no. 001)
- 2026-08-11 Filing 10-Q filed
- 2026-08-11 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-20 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-07-17 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 8.01 other event; Item 9.01 exhibits
- 2026-07-06 Filing 8-K filed: Item 5.02 officer or director change
- 2026-06-04 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-05-12 Filing 10-Q filed
- 2026-05-12 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-04-24 Filing ARS filed
- 2026-04-24 Filing DEFA14A filed
- 2026-04-24 Filing DEF 14A filed
- 2026-04-13 Filing EFFECT filed
- 2026-04-13 Filing EFFECT filed
- 2026-04-13 Filing 424B3 filed
- 2026-04-13 Filing 424B3 filed
- 2026-04-10 Filing 8-K filed: Item 5.02 officer or director change
- 2026-04-09 Filing CORRESP filed
- 2026-04-09 Filing CORRESP filed
- 2026-04-08 Filing UPLOAD filed
- 2026-04-08 Filing UPLOAD filed
- 2026-04-03 Filing S-3 filed
- 2026-04-03 Filing S-3 filed
- 2026-03-17 Filing S-8 filed
- 2021-01-01 Record plan effective date: KALARIS THERAPEUTICS, INC. 401(K) RETIREMENT PLAN
WHAT IS NOT HERE
Gaps
- Court records: not covered yet (expected 11-19).
- No H-1B LCA filed under EIN 831971007 in FY2026 Q3
- H-1B LCAs only (H-1B1 and E-3 excluded); one fiscal quarter (FY2026 Q3) only, earlier quarters not loaded
- Plan year 2025 only (EFAST2 'Latest' file); earlier years not loaded
- Administrator, signer and preparer names are not kept; sponsor (employer) name only
- Total assets shown only where the plan attached Schedule H (small plans file Schedule I or none)
- Participants: counts at the beginning and at the end of the plan year (end of year includes active, retired and separated participants)
- No Form 990 found for EIN 831971007
- USAspending: no recipient whose SAM legal name and address match this SEC filer
SOURCES AND LICENSE
Sources
- SEC EDGAR: checked · 2026-11-22T00:09:58Z
- DOL OFLC LCA Disclosure Data: checked, nothing found · 2026-11-22T00:09:59Z
- DOL EBSA Form 5500 public datasets: checked · 2026-11-22T00:09:59Z
- Propublica 990: checked, nothing found · 2026-11-22T00:09:59Z
- SEC 13F holdings: checked · 2026-11-22T00:09:59Z
- USAspending: checked, nothing found · 2026-11-22T00:10:02Z
CC BY 4.0 -- credit Seraphix Systems.
API
Use this record
Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.